All In Biotech

Drug Trial Radar · NCT00098358

Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Proof of Concept Study of Zileuton IR in Patients With Moderate to Severe Facial Acne Vulgaris

Last checked: Nov 20, 2026Latest source record: Feb 7, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

90

Actual

Start

Nov 2004

Primary completion

Not stated

Study completion May 2005

Sponsor

Lead sponsor
Critical TherapeuticsIndustry
Sponsor type
Industry
First posted
Dec 8, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Tissue inflammation is a major component of the acne disease process. Leukotriene B4 (LTB4) is thought to be a major player in the development of tissue inflammation. Synthesis of LTB4 is controlled by the enzyme 5-lipoxygenase. Zileuton blocks the activity of 5-lipoxygenase. This study will test the safety and efficacy of zileuton in the treatment of facial acne.

Conditions

  • Acne Vulgaris

Interventions

  • ZileutonDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in number of inflammatory lesions

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Therapeutics Clinical Research

    San Diego, California

  • MedaPhase, Inc.

    Newnan, Georgia

  • Dermatology Specialists, PSC

    Louisville, Kentucky

  • Minnesota Clinical Study Center

    Fridley, Minnesota

  • Academic Dermatology Associates

    Albuquerque, New Mexico

  • SUNY Downstate Medical Center

    Brooklyn, New York

  • Dermatology Associates of Rochester

    Rochester, New York

  • Milton S. Hersey Medical Center

    Hersey, Pennsylvania

  • Rivergate Dermatology

    Goodlettsville, Tennessee

  • DermResearch, Inc.

    Austin, Texas

  • J&S Studies, Inc.

    Bryan, Texas

  • Virginia Clinical Research, Inc.

    Norfolk, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.